Showing results (41-50 of 196) with videos related to
Sort By:
Pageof 20
The Journal of Surgical Research|November 4, 2004
Depletion of activated Vbeta8+ T cells disrupts bispecific antibody directed antitumor immunityElizabeth J McConnell, Elisabeth C McLemore, Robert Talac, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 24, 2017
IGF1R Protein Expression Is Not Associated with Differential Benefit to Concurrent Trastuzumab in Early-Stage HER2+ Breast Cancer from the North Central Cancer Treatment Group (Alliance) Adjuvant Trastuzumab Trial N9831Monica M Reinholz, Beiyun Chen, Amylou C Dueck, et al.Psycho-Oncology|May 22, 2015
Social support and its implications in older, early-stage breast cancer patients in CALGB 49907 (Alliance A171301)Aminah Jatoi, Hyman Muss, Jake B Allred, et al.Annals of Surgery|April 19, 2014
Methods of quality assurance in multicenter trials in laparoscopic colorectal surgery: a systematic reviewJake D Foster, Hugh Mackenzie, Heidi Nelson, et al.Archives of Surgery (Chicago, Ill. : 1960)|December 10, 2003
Vaginal reconstruction following resection of primary locally advanced and recurrent colorectal malignanciesDougal N D'Souza, Miguel Pera, Heidi Nelson, et al.Paediatric and Perinatal Epidemiology|October 25, 2018
Short interpregnancy intervals and adverse perinatal outcomes in high-resource settings: An updated systematic reviewKatherine A Ahrens, Heidi Nelson, Reva L Stidd, et al.Annals of Surgical Oncology|March 9, 2006
Is en-bloc resection of locally recurrent rectal carcinoma involving the urinary tract indicated?Luca Stocchi, Heidi Nelson, Daniel J Sargent, et al.Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|August 6, 2014
Perioperative patient-reported outcomes predict serious postoperative complications: a secondary analysis of the COST trialJuliane Bingener, Jeff A Sloan, Paul J Novotny, et al.Annals of Surgical Oncology|July 11, 2018
The Feasibility of Breast-Conserving Surgery for Multiple Ipsilateral Breast Cancer: An Initial Report from ACOSOG Z11102 (Alliance) TrialKari M Rosenkranz, Karla Ballman, Linda McCall, et al.Annals of Surgical Oncology|July 24, 2020
Cosmetic Outcomes Following Breast-Conservation Surgery and Radiation for Multiple Ipsilateral Breast Cancer: Data from the Alliance Z11102 StudyKari M Rosenkranz, Karla Ballman, Linda McCall, et al.Pageof 20